New clinical criteria defines acute-onset neuropsychiatric symptoms

Article

A working group has proposed a set of criteria to define a newly named entity - pediatric acute-onset neuropsychiatric syndrome - the most important of which is an abrupt, dramatic onset of obsessive-compulsive symptoms.

A working group has proposed a set of criteria to define a newly named entity-pediatric acute-onset neuropsychiatric syndrome (PANS)-the most important of which is an abrupt, dramatic onset of obsessive-compulsive (OC) symptoms.

The new entity describes a syndrome broader in scope than the clinically similar pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) and pediatric infection-triggered autoimmune neuropsychiatric disorders (PITANDS), both of which rely on a preceding infection for diagnosis. In contrast, PANS encompasses neuropsychiatric syndromes with both infectious and noninfectious triggers.

Based on clinical data from 400 children and adolescents who had been diagnosed with PANDAS, the group proposed diagnostic criteria for PANS:

Swedo SE, Leckman JF, Rose NR. From research subgroup to clinical syndrome: modifying the PANDAS criteria to describe PANS (Pediatric Acute-onset Neuropsychiatric Syndrome). Pediatr Therapeut. 2012;2(2):113. doi: 10.4172/2161-0665.1000113.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Recent Videos
Lori Handy, MD on importance of vaccine catch-up before the school year | Image credit: CHOP
Richard Wong, DO, explains challenges children with asthma face in school
Infectious Insights | Image Credit: Contemporary Pediatrics
John Browning, MD, provides practical skincare reminders ahead of summer season
Potential downstream benefits of RSV preventive measures, with Octavio Ramilo, MD
Discussing phase 3 data of Panzyga for PANS, with Michael Daines, MD
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
© 2025 MJH Life Sciences

All rights reserved.